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Abstract: Loss-of-function mutations in the FLG gene (encoding the epidermis-specific protein filaggrin) were recently 
shown to be associated with atopic dermatitis in several populations. These findings have challenged the dogma that 
atopic dermatitis is primarily an immune-mediated disease, and suggest skin barrier deficiency as a major cause. 
Similarly, psoriasis was until recently regarded as a T-cell driven disease caused by (auto)immune mechanisms. This view 
is supported by clinical data, and several genetic studies have identified risk factors associated with a function in adaptive 
immunity such as HLA-Cw6. Analysis of the PSORS4 region on chromosome 1q, however, has recently identified the 
deletion of late cornified envelope (LCE) genes LCE3B/C as novel psoriasis genes with a considerable population 
attributable risk. Because these genes are expressed in epithelial cells and not by the immunocytes, these findings have 
changed our view on psoriasis. The mechanism by which loss of LCE3B/C genes predisposes to psoriasis is unclear as 
both genes are not expressed in normal skin but appear to be induced upon skin barrier disruption or inflammation. We 
hypothesize that psoriasis could be the result of an interplay of immunological mechanisms and deficient repair of skin 
barrier integrity. Altogether, these findings demonstrate that in addition to immune mechanisms, genetic variation of skin 
barrier genes contribute to major skin diseases such as atopic dermatitis and psoriasis. 
Keywords: Atopic dermatitis, epidermal differentiation complex, filaggrin, late cornified envelope, LCE3B/C deletion, 
psoriasis. 
GENETIC STUDIES ON SKIN DISEASES: INVOLVE-
MENT OF THE EPIDERMAL DIFFERENTIATION 
COMPLEX 
 Atopic dermatitis and psoriasis are clinically distinct, 
chronic inflammatory skin diseases with a strong genetic 
basis, and are extensively reviewed [1-5]. Several genome-
wide analyses have been performed to discover genetic 
factors contributing to atopic dermatitis and psoriasis. These 
analyses have revealed chromosomal regions harboring 
possible susceptibility loci for both diseases on chromosomal 
regions 1q21, 3q21, 17q25 and 20p12. In this review we will 
focus on the overlapping locus on 1q21, for psoriasis the so-
called psoriasis susceptibility (PSORS) 4 locus. This shared 
locus overlies the epidermal differentiation complex (EDC) 
(see Fig. 1), a cluster of genes encoding proteins found in the 
uppermost layers of the epidermis, which are of great 
importance for keratinocyte differentiation and skin barrier 
maintenance [6]. Genes located in the EDC include loricrin 
(LOR), involucrin (IVL), filaggrin (FLG), the small proline 
rich protein (SPRR) genes and the late cornified envelope 
(LCE) genes. This last cluster, with a total of 18 members, is 
divided into six families, LCE1-6, based on related amino 
acid sequences, genomic organization and expression 
patterns [7]. The focus on genes involved in skin barrier 
function as susceptibility factors for atopic dermatitis and 
psoriasis is not entirely new. Studies on permeability, barrier  
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function and morphological examinations of patients’ 
epidermis demonstrated an impaired barrier function for both 
diseases [8, 9]. Already in 1999, it was proposed that a 
genetic predisposition to a defective skin barrier was a 
primary event in the development of atopic dermatitis, 
allowing allergen penetration and enhanced Th2 responses 
[10]. 
THE FILAGGRIN ATOPIC DERMATITIS CONNECT-
ION: A CHANGE OF PARADIGM 
 In atopic dermatitis, until recently regarded as a primarily 
immune-mediated condition, the disrupted barrier function 
of the skin is now considered as a major cause of the disease. 
Loss-of-function mutations in FLG were shown to be 
associated with atopic dermatitis in several populations [11, 
12]. Large population based studies show a population 
attributable risk (PAR) of 13.5%. As the FLG gene is located 
in or near PSORS4, FLG mutations were also studied in 
psoriasis patients, however no associations were found [13]. 
 Filaggrin is specifically expressed in the epidermis, 
where it has a function in the aggregation of keratin 
filaments, which is necessary for the formation of the 
stratum corneum [14]. Subsequently, within the stratum 
corneum, filaggrin is degraded into a pool of hydrophilic 
amino acids, which make up the natural moisturizing factor 
(NMF). These molecules play a central role in maintaining 
the hydration of the stratum corneum. NMF levels have been 
shown to correlate with FLG null allele status, and may 
therefore directly contribute to the dry skin phenotype seen 
in atopic dermatitis [15]. In addition to the structural 
properties of filaggrin, a filaggrin breakdown product, 
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urocanic acid, is a UV-absorbing molecule [16] and the cis-
isomer has local and systemic immunosuppressive effects, 
which is demonstrated in murine models and in human 
keratinocytes and leukocytes in vitro [17]. 
 Interestingly, also the cytokine environment associated 
with atopic dermatitis appears to contribute to compromised 
skin barrier function, as interleukin-4 and interleukin-13 
suppress filaggrin gene expression [18]. Studies on flaky tail 
mice, harboring a mutation analogous to the common human 
FLG mutation, demonstrated that topical application of 
allergens resulted in cutaneous infiltration and an allergen-
specific antibody response. These data demonstrate that 
antigen transfer through a defective epidermal barrier could 
be a key mechanism in atopic diseases [19]. 
IDENTIFICATION OF THE LCE3B/C DELETION AS 
THE PSORIASIS ASSOCIATED RISK FACTOR IN 
THE PSORS4 LOCUS 
 The question if psoriasis is an epithelial disease or an 
immune-mediated disease has generated considerable debate 
over the last decades, but remains essentially unresolved. 
Until the early eighties psoriasis was considered to be a 
keratinocyte disease, but the advent of cyclosporin A as an 
effective mechanism-based treatment has changed this [20]. 
Many studies have even assumed an autoimmune basis of 
psoriasis. This was, however, largely founded on 
circumstantial evidence, as autoantibodies or autoreactive T-
cells have never been demonstrated. For the last three 
decades psoriasis was primarily regarded as an immune-
mediated disease although this view is changing rapidly [21, 
22]. Independent genetic studies have shown that PSORS1 is 
the strongest and invariably reproduced psoriasis 
susceptibility locus. This locus contains several genes 
including HLA-Cw6, involved in adaptive immunity, and 
corneodesmosin (CDSN), encoding a skin barrier protein 
expressed in differentiated keratinocytes. However, due to 
linkage disequilibrium (LD), the tendency of two genes to be 
inherited together more often than would be predicted by 
chance, it is difficult to identify the true causative 
susceptibility gene of the PSORS1 locus [23-25]. 
 Although most of the available genetic and clinical data 
supported a role for T-cell driven processes, the importance 
of epidermis-expressed genes could not be ruled out 
completely. In addition to the genetic association with 
PSORS4 and the possible role of CDSN, cell biological 
studies implied that keratinocytes of psoriatic patients are 
intrinsically different from keratinocytes of healthy controls 
or atopic dermatitis patients. Cultured keratinocytes from 
patients were found to react differently to stimuli like 
cytokines, most likely due to genetically programmed 
differences [26, 27]. 
 A hallmark of lesional psoriatic skin is premature 
keratinocyte differentiation and disturbed keratinization, 
including altered formation of the cornified envelope. In 
psoriatic skin the components of the cornified envelope are 
differentially expressed as compared to normal skin. The 
expression of the early differentiation markers like 
involucrin, corneodesmosin, the small proline-rich proteins, 
cystatin A and transglutaminase 1 is upregulated, while the 
expression of the late differentiation markers like loricrin 
and filaggrin is downregulated [28, 29]. The defective 
formation of the cornified envelope influences the barrier 
capacity of the skin in psoriasis patients. Several 
independent studies demonstrated that the transepidermal 
water loss (TEWL) of lesional psoriatic skin is higher 
compared to the TEWL of normal and uninvolved psoriatic 
skin. Furthermore, the level of the TEWL is related to the 
clinical severity of the lesion, suggesting that the barrier 
function of lesional psoriatic skin is weaker than in normal 
skin [30, 31]. Another indication for the involvement of the 
physical barrier function of the skin is the Koebner 
phenomenon, i.e. the appearance of psoriatic lesions in 
uninvolved skin of psoriatic patients as a consequence of 
superficial trauma [32]. 
 Until recently, no genetic association of specific EDC 
genes, e.g FLG and LOR, with psoriasis was found. De Cid 
et al. [33], however, demonstrated an association of the 
deletion of LCE3B and LCE3C with psoriasis in populations 
from Spain, Italy, The Netherlands and the USA. This 
 
Fig. (1). Overview of the EDC region on chromosome 1. The EDC region is shown in the top half of the diagram, with the genes LOR, the 
SPRR family, IVL and FLG highlighted. Loss-of-function mutations in FLG are associated with atopic dermatitis. In the lower half of the 
diagram a part of the LCE cluster, which consists of a total of 18 genes, is present. The deletion of LCE3B and LCE3C (highlighted) is 
associated with psoriasis. Adapted by permission from Macmillan Publishers Ltd: J Invest Dermatol [7], copyright 2005. 
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common deletion was found with a higher frequency in 
psoriasis patients (68%) compared to controls (59%) with a 
corresponding PAR of 23%. These results have been 
replicated in a German cohort [34]. In addition, in an 
independent genome wide association study of a large 
Chinese cohort, single nucleotide polymorphisms (SNPs) in 
strong LD with the LCE3B/C deletion were identified as risk 
factors for psoriasis [35]. Interestingly, the LCE3B/C 
deletion was not found to be associated with psoriatic 
arthritis [36]. 
 In order to investigate the putative function of the 
LCE3B and LCE3C proteins, De Cid et al. [37] investigated 
the expression of the LCE3C (located in the deletion, and 
therefore absent in some individuals) and LCE3E genes (not 
located in the deletion and therefore used as a reference) in 
epidermal sheets of normal and psoriatic skin. The 
expression of LCE3C and LCE3E was hardly detectable in 
normal and uninvolved psoriatic skin. Though, in lesional 
psoriatic skin, both LCE3C (when at least one intact LCE3C 
allele was present) and LCE3E were highly induced. To 
examine if skin barrier disruption might be a 
pathophysiological stimulus for LCE3 expression, LCE3C 
and LCE3E expression was analysed in healthy individuals 
following minor skin injury by tape stripping. Indeed, in 
normal skin both genes were induced upon tape stripping, 
suggesting that induction of these genes is a repair response. 
 The LCE genes have not been extensively studied. In 
mice, Marshall and colleagues [37] showed that members of 
the LCE family of proteins are incorporated into the 
cornified envelope via crosslinking by transglutaminases 
rather late in the process of epidermal differentiation, and it 
was proposed that these proteins modulate barrier activity on 
the skin surface. Jackson et al. [7] demonstrated that LCE1 
and 2 family members are primarily expressed in skin, and 
that they are barely expressed in internal epithelia. The LCE3 
family members are variably expressed at low levels in 
epithelia, and they show varying expression between tissue 
types. LCE4 and LCE5 expression was hardly detected in the 
investigated tissues. LCE6 expression was not analysed. In 
cultured keratinocytes, Jackson et al. [7] revealed that the 
LCE2 expression is induced by calcium, and UV induces the 
expression of the LCE1 and LCE2 families and of the 
LCE3E gene. 
CONCLUDING REMARKS 
 Genetic studies on inflammatory skin diseases, and on 
complex diseases in general, have proven to be useful tools 
to provide new insight into their pathophysiology. For atopic 
dermatitis, mutations found in FLG have challenged the 
dogma that atopic dermatitis is primarily an immune-
mediated disease, and suggest skin barrier deficiency as a 
major cause. The association of the deletion of LCE3B and 
LCE3C with psoriasis is the first replicated susceptibility 
factor in the EDC, for this disease. We can only hypothesize 
about the role of the LCE3B/C deletion in the pathogenesis 
of psoriasis. Since the expression of LCE3C is induced after 
barrier disruption, we propose that incomplete barrier repair 
after minor injury might lead to penetration of environmental 
antigens or stimuli through the skin. These could trigger an 
inflammatory process that leads to psoriasis. Clearly, the 
molecular details of such a scenario need to be elucidated. 
The nature of the environmental stimuli is at present unclear 
but microbial components e.g. from Streptococcus spp. 
would be excellent candidates. In general, components from 
the commensal flora or transient infection of throat and gut 
could very well trigger skin inflammation. The recently 
initiated human microbiome project is likely to contribute to 
novel insights in the pathogenesis of inflammatory skin 
diseases [38, 39]. Analysis of the skin microbiome in 
psoriasis patients and controls has already revealed 
differences in microbial community structure [40]. 
 Altogether, these findings demonstrate that in addition to 
immune mechanisms, genetic variation of skin barrier genes 
contribute to major skin diseases such as atopic dermatitis 
and psoriasis. 
ABBREVIATIONS 
CDSN = Corneodesmosin 
EDC = Epidermal differentiation complex 
FLG = Filaggrin 
IVL = Involucrin 
LCE = Late cornified envelope 
LD = Linkage disequilibrium 
LOR = Loricrin 
NMF = Natural moisturizing factor 
PAR  = Population attributable risk 
PSORS = Psoriasis susceptibility locus 
SNPs = Single nucleotide polymorphisms 
SPRR = Small proline rich protein genes 
TEWL = Transepidermal water loss 
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